Pharma/Fine Chemicals Roundup – October 11

AESICA FORMS ALLIANCE WITH NORAMCO Aesica Pharmaceuticals (Newcastle upon Tyne, U.K.), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says it has formed a manufacturing alliance with Noramco (Athens, GA), a manufacturer of opiate-derived APIs. The alliance involves a technical transfer of a process for the manufacture of codeine phosphate from a patented poppy supplied by Noramco’s affiliate, Tasmanian Alkaloids (Westbury, Australia), allowing for the conversion of the extracted alkaloid to a finished API in a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers